Johnson & Johnson's Imbruvica Scores Expanded FDA Approval for Chronic Graft vs Host Disease Post author:Sam Post published:August 2, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Rumored Acquisition Target Bristol-Myers Squibb Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback February 20, 2017 Theranos CEO Gives Up Own Shares to Investors to Avoid Being Sued March 23, 2017 Pharma Scores Big Win: to Ink FDA User Fee Bill, Saving 5,000 Jobs August 3, 2017
Rumored Acquisition Target Bristol-Myers Squibb Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback February 20, 2017